Li Zhu

1.8k total citations
51 papers, 1.5k citations indexed

About

Li Zhu is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Li Zhu has authored 51 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 12 papers in Organic Chemistry and 8 papers in Pharmacology. Recurrent topics in Li Zhu's work include Plant-derived Lignans Synthesis and Bioactivity (11 papers), ATP Synthase and ATPases Research (7 papers) and Inflammatory mediators and NSAID effects (7 papers). Li Zhu is often cited by papers focused on Plant-derived Lignans Synthesis and Bioactivity (11 papers), ATP Synthase and ATPases Research (7 papers) and Inflammatory mediators and NSAID effects (7 papers). Li Zhu collaborates with scholars based in China, United States and Austria. Li Zhu's co-authors include Yu Zhao, Sherven Sharma, Steven M. Dubinett, Raj K. Batra, Felicita Baratelli, Seok-Chul Yang, Karen L. Reckamp, Brian Gardner, Min Huang and Jie Luo and has published in prestigious journals such as Cancer Research, Chemical Communications and The FASEB Journal.

In The Last Decade

Li Zhu

50 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Zhu China 19 605 417 413 316 264 51 1.5k
Carina L. Bos Netherlands 14 473 0.8× 205 0.5× 212 0.5× 267 0.8× 105 0.4× 17 1.4k
Joanne R. Brown United Kingdom 11 459 0.8× 286 0.7× 339 0.8× 463 1.5× 71 0.3× 13 1.3k
Weigang Tong United States 18 632 1.0× 139 0.3× 270 0.7× 451 1.4× 80 0.3× 30 1.4k
Edward F. Webb United States 20 778 1.3× 341 0.8× 267 0.6× 193 0.6× 280 1.1× 36 1.7k
Baskaran Govindarajan United States 21 1000 1.7× 276 0.7× 412 1.0× 77 0.2× 210 0.8× 26 1.8k
Francesca Tosetti Italy 23 1.1k 1.8× 397 1.0× 502 1.2× 141 0.4× 77 0.3× 48 2.0k
Jason R. Mann United States 13 491 0.8× 171 0.4× 350 0.8× 706 2.2× 69 0.3× 14 1.4k
Gillian Hawcroft United Kingdom 15 447 0.7× 175 0.4× 277 0.7× 568 1.8× 69 0.3× 17 1.2k
Johannes Kreuzer United States 15 801 1.3× 242 0.6× 277 0.7× 105 0.3× 203 0.8× 25 1.5k
Federica Finetti Italy 18 499 0.8× 141 0.3× 190 0.5× 230 0.7× 92 0.3× 46 1.1k

Countries citing papers authored by Li Zhu

Since Specialization
Citations

This map shows the geographic impact of Li Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Zhu more than expected).

Fields of papers citing papers by Li Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Zhu. The network helps show where Li Zhu may publish in the future.

Co-authorship network of co-authors of Li Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Li Zhu. A scholar is included among the top collaborators of Li Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Zhu. Li Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leng, Yifei, Ying Zhang, Xiong Chen, et al.. (2025). Enhanced transformation of sulfadiazine by horseradish peroxidase activated persulfate progress: Characteristics, pathways, mechanisms, and ecotoxicities. Journal of environmental chemical engineering. 13(3). 116140–116140. 1 indexed citations
2.
Cai, Rui, et al.. (2022). 2, 4, 5‐Trideoxyhexopyranosides derivatives of diphyllin: Synthesis and anticancer activity. Chemical Biology & Drug Design. 100(2). 256–266. 6 indexed citations
3.
Zhu, Li, et al.. (2021). CtD strategy to construct stereochemically complex and structurally diverse compounds from griseofulvin. Chemical Communications. 57(82). 10755–10758. 4 indexed citations
4.
Wang, Xiaotian, Kang Cheng, & Li Zhu. (2021). Гипоксия ускоряет экспрессию β-актина через активацию транскрипции ACTB ядерным фактором дыхания-1. Молекулярная биология. 55(3). 460–467. 1 indexed citations
5.
Cai, Rui, Li Zhu, Weidong Shen, & Yu Zhao. (2019). Synthesis, cytotoxicity and anti-invasion activity of three natural diphyllin L-arabinopyranosides. Fitoterapia. 137. 104198–104198. 7 indexed citations
6.
Liu, Siyuan, Lu Wang, Wangwang Ding, et al.. (2019). Cleistanthin A inhibits the invasion of MDA-MB-231 human breast cancer cells: involvement of the β-catenin pathway. Pharmacological Reports. 72(1). 188–198. 10 indexed citations
7.
Liu, Jing, Ping Yang, Minhui Li, et al.. (2016). Inhibition of disheveled-2 resensitizes cisplatin-resistant lung cancer cells through down-regulating Wnt/β-catenin signaling. Experimental Cell Research. 347(1). 105–113. 34 indexed citations
8.
Zhao, Yu, Rui Zhang, Yapeng Lu, Jinlong Ma, & Li Zhu. (2015). Synthesis and bioevaluation of heterocyclic derivatives of Cleistanthin-A. Bioorganic & Medicinal Chemistry. 23(15). 4884–4890. 14 indexed citations
9.
Lu, Yapeng, Rui Zhang, Siyuan Liu, et al.. (2015). ZT-25, a new vacuolar H+-ATPase inhibitor, induces apoptosis and protective autophagy through ROS generation in HepG2 cells. European Journal of Pharmacology. 771. 130–138. 47 indexed citations
10.
Zhu, Li. (2012). Construction and identification of eukaryotic expression plasmid of human Iron regulation protein1 and function in HepG2 cells. 2 indexed citations
11.
Zhao, Yu, Chun‐Yan Ni, Yuting Zhang, & Li Zhu. (2012). Synthesis and Bioevaluation of Diphyllin Glycosides as Novel Anticancer Agents. Archiv der Pharmazie. 345(8). 622–628. 20 indexed citations
12.
Wang, Chengniu, et al.. (2011). Synthesis and Cytotoxicity Evaluation of Novel Podophyllotoxin Derivatives. Archiv der Pharmazie. 344(11). 735–740. 7 indexed citations
13.
Zhao, Yu, et al.. (2010). Synthesis and antitumor activity of novel aroylthiourea derivatives of podophyllotoxin. Investigational New Drugs. 30(1). 17–24. 23 indexed citations
14.
Meng, Jia, et al.. (2009). Highly Efficient Access to Bi‐ and Tricyclic Ketals through Gold‐Catalyzed Tandem Reactions of 4‐Acyl‐1,6‐diynes. Chemistry - A European Journal. 15(8). 1830–1834. 37 indexed citations
15.
Zhao, Yu, et al.. (2009). Synthesis and bioevaluation of novel analogues of justicidin A. Medicinal Chemistry Research. 19(1). 71–76. 11 indexed citations
16.
Zhu, Li, et al.. (2008). Synthesis of Per‐acetyld‐fucopyranosyl Bromide and Its Use in Preparation of Diphyllind‐fucopyranosyl Glycoside. Journal of Carbohydrate Chemistry. 27(2). 113–119. 16 indexed citations
17.
Schett, Georg, Scot Middleton, Brad Bolon, et al.. (2005). Additive bone‐protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models. Arthritis & Rheumatism. 52(5). 1604–1611. 54 indexed citations
18.
Schett, Georg, Marina Stolina, Brad Bolon, et al.. (2005). Analysis of the kinetics of osteoclastogenesis in arthritic rats. Arthritis & Rheumatism. 52(10). 3192–3201. 51 indexed citations
19.
Zhu, Li, et al.. (2005). [Prevention of Rhodiola-astragalus membranaceus compounds against simulated plateau hypoxia brain injury in rat].. PubMed. 18(4). 303–5. 1 indexed citations
20.
Heuzé‐Vourc'h, Nathalie, Li Zhu, Kostyantyn Krysan, et al.. (2003). Abnormal interleukin 10Ralpha expression contributes to the maintenance of elevated cyclooxygenase-2 in non-small cell lung cancer cells.. PubMed. 63(4). 766–70. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026